Request a document copy: A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG)

all files (of this document) in restricted access
the file(s) you requested
Cancel